Related Experiment Video
Updated: Jun 2, 2026

Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle (GUV) Membranes
Published on: July 28, 2016
The role of glycosphingolipids in HIV/AIDS
Clifford A Lingwood1, Donald R Branch
1Molecular Structure and Function Program, Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract:
Much remains unknown about basic aspects of HIV-1 infection and cell susceptibility. Glycosphingolipid (GSL) binding by the HIV-1 adhesin gp120 has long been implicated in the infection of non-lymphoid cells, as well as CD4(+) T cells and monocytes, the primary targets of HIV-1 infection. We have identified the P(k) blood group antigen (a GSL) globotriaosylceramide (Gb(3)) as a new resistance effector against HIV-1 infection. Significantly, the α-galactosyltransferase (A4GALT, Gb(3) synthase) responsible for the synthesis of Gb(3) is included among markers genetically linked to HIV-1 resistance. Other GSLs, including GalCer and GM3, have been implicated as facilitators of HIV infection. This review will address the role of GSLs in HIV/AIDS but focus on the role of Gb(3) as a newly described natural resistance factor for the prevention of HIV infection and examine potential therapies that would utilize soluble analogues of this unique GSL.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Proteoglycans
Glycocalyx and its Functions
Components of...
Protein Glycosylation
Glycosylation occurs in...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles

